These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 16153409

  • 41. Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages.
    Proudfoot L, O'Donnell CA, Liew FY.
    Eur J Immunol; 1995 Mar; 25(3):745-50. PubMed ID: 7705404
    [Abstract] [Full Text] [Related]

  • 42. Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages.
    Brandonisio O, Panaro MA, Fumarola I, Sisto M, Leogrande D, Acquafredda A, Spinelli R, Mitolo V.
    Clin Exp Med; 2002 Nov; 2(3):125-9. PubMed ID: 12447609
    [Abstract] [Full Text] [Related]

  • 43. Macrophage activation: a riddle of immunological resistance.
    Crawford RM, Leiby DA, Green SJ, Nacy CA, Fortier AH, Meltzer MS.
    Immunol Ser; 1994 Nov; 60():29-46. PubMed ID: 8251575
    [Abstract] [Full Text] [Related]

  • 44. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production.
    Forget G, Gregory DJ, Whitcombe LA, Olivier M.
    Infect Immun; 2006 Nov; 74(11):6272-9. PubMed ID: 17057094
    [Abstract] [Full Text] [Related]

  • 45. Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani.
    Bories C, Cojean S, Huteau F, Loiseau PM.
    Biomed Pharmacother; 2008 Mar; 62(3):164-7. PubMed ID: 18249083
    [Abstract] [Full Text] [Related]

  • 46. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
    Néris PL, Caldas JP, Rodrigues YK, Amorim FM, Leite JA, Rodrigues-Mascarenhas S, Barbosa-Filho JM, Rodrigues LC, Oliveira MR.
    Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
    [Abstract] [Full Text] [Related]

  • 47. Leishmania initially activates but subsequently down-regulates intracellular mitogen-activated protein kinases and nuclear factor-kappaB signaling in macrophages.
    Ben-Othman R, Guizani-Tabbane L, Dellagi K.
    Mol Immunol; 2008 Jun; 45(11):3222-9. PubMed ID: 18406464
    [Abstract] [Full Text] [Related]

  • 48. Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages.
    Vila-del Sol V, Díaz-Muñoz MD, Fresno M.
    J Leukoc Biol; 2007 Jan; 81(1):272-83. PubMed ID: 17035338
    [Abstract] [Full Text] [Related]

  • 49. Structure-activity relationship and studies on the molecular mechanism of leishmanicidal N,C-coupled arylisoquinolinium salts.
    Ponte-Sucre A, Gulder T, Wegehaupt A, Albert C, Rikanović C, Schaeflein L, Frank A, Schultheis M, Unger M, Holzgrabe U, Bringmann G, Moll H.
    J Med Chem; 2009 Feb 12; 52(3):626-36. PubMed ID: 19117415
    [Abstract] [Full Text] [Related]

  • 50. Nitric oxide synthase and cytokines gene expression analyses in Leishmania-infected RAW 264.7 cells treated with an extract of Pelargonium sidoides (Eps 7630).
    Trun W, Kiderlen AF, Kolodziej H.
    Phytomedicine; 2006 Sep 12; 13(8):570-5. PubMed ID: 16920512
    [Abstract] [Full Text] [Related]

  • 51. Leishmanicidal activity of aurones.
    Kayser O, Kiderlen AF.
    Tokai J Exp Clin Med; 1998 Dec 12; 23(6):423-6. PubMed ID: 10622641
    [Abstract] [Full Text] [Related]

  • 52. Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani.
    Wert L, Alakurtti S, Corral MJ, Sánchez-Fortún S, Yli-Kauhaluoma J, Alunda JM.
    J Antibiot (Tokyo); 2011 Jul 12; 64(7):475-81. PubMed ID: 21522160
    [Abstract] [Full Text] [Related]

  • 53. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.
    Clin Ter; 2006 Jul 12; 157(4):377-86. PubMed ID: 17051976
    [Abstract] [Full Text] [Related]

  • 54. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro.
    Vendrame CM, Carvalho MD, Rios FJ, Manuli ER, Petitto-Assis F, Goto H.
    Scand J Immunol; 2007 Jul 12; 66(2-3):287-96. PubMed ID: 17635806
    [Abstract] [Full Text] [Related]

  • 55. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
    Singh N, Gupta R, Jaiswal AK, Sundar S, Dube A.
    J Antimicrob Chemother; 2009 Aug 12; 64(2):370-4. PubMed ID: 19525291
    [Abstract] [Full Text] [Related]

  • 56. Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence.
    Iyer JP, Kaprakkaden A, Choudhary ML, Shaha C.
    Mol Microbiol; 2008 Apr 12; 68(2):372-91. PubMed ID: 18312262
    [Abstract] [Full Text] [Related]

  • 57. Toxin gamma from Tityus serrulatus scorpion venom plays an essential role in immunomodulation of macrophages.
    Petricevich VL, Hernández Cruz A, Coronas FI, Possani LD.
    Toxicon; 2007 Oct 12; 50(5):666-75. PubMed ID: 17675201
    [Abstract] [Full Text] [Related]

  • 58. Aziridine-2,3-dicarboxylates, peptidomimetic cysteine protease inhibitors with antileishmanial activity.
    Ponte-Sucre A, Vicik R, Schultheis M, Schirmeister T, Moll H.
    Antimicrob Agents Chemother; 2006 Jul 12; 50(7):2439-47. PubMed ID: 16801424
    [Abstract] [Full Text] [Related]

  • 59. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
    Aranha FC, Ribeiro U, Basse P, Corbett CE, Laurenti MD.
    Scand J Immunol; 2005 Oct 12; 62(4):334-41. PubMed ID: 16253120
    [Abstract] [Full Text] [Related]

  • 60. Changes in the proteome and infectivity of Leishmania infantum induced by in vitro exposure to a nitric oxide donor.
    Dea-Ayuela MA, Ordoñez-Gutierrez L, Bolás-Fernández F.
    Int J Med Microbiol; 2009 Mar 12; 299(3):221-32. PubMed ID: 18774335
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.